Secukinumab shows positive effects in HS at 52 weeks
Patients with moderate to severe hidradenitis suppurativa (HS) treated with secukinumab demonstrate sustained efficacy and symptom...
top of page
it's where dermatology lives
John Evans
Feb 14, 20222 min read
Psoriatic inflammation improves with bile acids
Some bile acids may help to improve or prevent the skin inflammation associated with psoriasis, according to the results of a study...
John Evans
Aug 9, 20211 min read
Two-year data indicates bimekizumab maintains high levels of psoriatic skin clearance
Study results indicate that maintenance doses of bimekizumab (320 mg) every four or eight weeks can maintain high levels of skin...
Featured Posts
bottom of page